Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00075777 · ClinicalTrials.gov registry record · NA
Valproic Acid in Treating Patients With Kaposi's Sarcoma
A NA study, sponsored by AIDS Malignancy Consortium.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT00075777: Completed NA study, sponsored by AIDS Malignancy Consortium.
NCT00075777 is a NA study that has completed, run by AIDS Malignancy Consortium. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00075777, a NA study, has completed, sponsored by AIDS Malignancy Consortium.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
RATIONALE: Valproic acid may help stop the growth of Kaposi's sarcoma cells by blocking the enzymes necessary for tumor cell growth. PURPOSE: This clinical trial is studying valproic acid in treating patients with HIV-related Kaposi's sarcoma.
Interventions
- DRUG valproic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2005-02 |
| Est. Completion | 2008-02 |
| Phase | NA |
What the finished NCT00075777 record still lists
NCT00075777 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which valproic acid is the first listed.
NCT00075777 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00075777 about?
NCT00075777 is a clinical study titled "Valproic Acid in Treating Patients With Kaposi's Sarcoma". RATIONALE: Valproic acid may help stop the growth of Kaposi's sarcoma cells by blocking the enzymes necessary for tumor cell growth. PURPOSE: This clinical trial is studying valproic acid in treating patients with HIV-related Kaposi's sarcoma.
What is the current status of trial NCT00075777?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2005-02. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00075777?
The interventions under investigation include: valproic acid (DRUG).
Who is sponsoring clinical trial NCT00075777?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00075777's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia